XML 22 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Acquisitions
6 Months Ended
Jun. 30, 2022
Asset Acquisition [Abstract]  
Acquisitions
4.
Acquisitions

 

AMMD

On April 8, 2022, the Company entered into a definitive agreement to acquire Allegany Medical Marijuana Dispensary ("AMMD"), a medical dispensary in Maryland from Moose Curve Holdings, LLC. Under the terms of the agreement, the Company will acquire 100% equity interest in AMMD for total consideration of $10,000 in cash, in addition to acquiring related real estate for $1,700. The transaction is subject to customary closing conditions and regulatory approvals. The Company intends to rebrand the 8,000 square foot dispensary as The Apothecarium.

 

Pinnacle

On April 14, 2022, the Company entered into a definitive agreement to acquire KISA Enterprises MI, LLC and KISA Holdings, LLC (collectively, "Pinnacle"), a dispensary operator in Michigan, and related real estate, for total consideration of $28,500, payable in cash, two promissory notes in an aggregate amount of $10,000, and stock. The transaction includes six retail dispensary licenses, five of which are currently operational and located in the cities of Addison, Buchanan, Camden, Edmore, and Morenci, Michigan. The Company intends to rebrand each of the dispensaries under either the Gage or Cookies retail brand. This transaction is pending approval.

 

Gage

On March 10, 2022, in order to expand its footprint in key markets, the Company acquired all of the issued and outstanding subordinate voting shares (or equivalent) of Gage, a cultivator and processor with operations in the Michigan market. Pursuant to the terms of the arrangement agreement, for each Gage subordinate voting share and other equity instruments, including outstanding stock options and warrants, each holder received a 0.3001 equivalent replacement award of the Company's respective security at the time of closing based on the closing price of the Common Shares on the Canadian Stock Exchange ("CSE") on March 10, 2022. On the acquisition date there was consideration in the form of 51,349,978 Common Shares valued at $207,871, 13,504,500 exchangeable units valued at $66,591, 4,940,364 replacement stock options with a fair value of $13,147, and 282,023 replacement warrants with a fair value of $435. Each of the directors, officers and 10% shareholders of Gage entered into voting support and lock-up agreements in which the shares issued to

these individuals are subject to various vesting periods. As such, a restriction discount of $45,336 has been placed over the shares subject to lock-up. The fair value of the replacement options and warrants was calculated using the Black Scholes Option Pricing Model combined with the percentage of the vesting period that was completed prior to the acquisition. Additionally, total consideration included warrant liabilities convertible into equity with a fair value of $6,756.

 

The following table presents the fair value of assets acquired and liabilities assumed as of the March 10, 2022 acquisition date and allocation of the consideration to net assets acquired:

 

 

 

$

 

Cash and cash equivalents

 

 

24,716

 

Accounts receivable

 

 

8,996

 

Inventory

 

 

20,852

 

Prepaid expenses and other current assets

 

 

1,855

 

Property and equipment

 

 

69,595

 

Operating right of use asset

 

 

1,948

 

Deposits

 

 

1,147

 

Intangible assets

 

 

187,953

 

Goodwill

 

 

150,272

 

Investments

 

 

4,121

 

Accounts payable and accrued liabilities

 

 

(29,871

)

Corporate income taxes payable

 

 

(5,000

)

Operating lease liability

 

 

(1,948

)

Finance lease liability

 

 

(308

)

Deferred revenue

 

 

(562

)

Loans payable

 

 

(60,605

)

Deferred tax liability

 

 

(59,603

)

Financing obligations

 

 

(12,184

)

Other liabilities

 

 

(6,574

)

Net assets acquired

 

 

294,800

 

 

 

 

 

Common shares of TerrAscend

 

 

274,462

 

Fair value of other equity instruments

 

 

13,582

 

Fair value of warrants classified as liabilities

 

 

6,756

 

Total consideration

 

 

294,800

 

 

The acquired intangible assets include cultivation and processing licenses, as well as retail licenses, which are treated as definite-lived intangible assets which are amortized over a 15 year period. The fair value of the cultivation and processing and the retail licenses are $77,198 and $53,321, respectively. In addition, the intangible assets include brand intangibles which are treated as indefinite lived intangible assets. The fair value of the brand intangibles is $57,435.

The consideration paid reflected the synergies, economies of scale, and workforce. These benefits were not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets. None of the goodwill recognized is expected to be deductible for income tax purposes.

The accounting for this acquisition has been provisionally determined at June 30, 2022. The fair value of net assets acquired, specifically with respect to inventory, intangible assets, deferred revenue, property and equipment, operating right of use assets, lease liabilities, investments, corporate income taxes payable, deferred tax liability, and goodwill have been determined provisionally and are subject to adjustment. Upon completion of a comprehensive valuation and finalization of the purchase price allocation, the amounts above may be adjusted retrospectively to the acquisition date in future reporting periods.

Costs related to this transaction were $3,949, including legal, accounting, due diligence, and other transaction-related expenses. Of the total amount of transaction costs, $1,309 was recorded during the six months ended June 30, 2022, and was included in transaction and restructuring costs in the consolidated statement of operations and comprehensive income.

On a standalone basis, had the Company acquired the business on January 1, 2022, sales estimates would have been $41,444 for the six months ended June 30, 2022 and net loss estimates would have been $(16,959). Actual sales and net loss for the six months ended June 30, 2022 since the date of acquisition are $28,928 and $(7,748), respectively.

Contingent consideration

Contingent consideration recorded relates to the Company’s business acquisitions. Contingent consideration is based upon the potential earnout of the underlying business unit and is measured at fair value using a projection model for the business and the formulaic structure for determining the consideration under the terms of the agreement.

The balance of contingent consideration is as follows:

 

 

 

State Flower

 

 

Apothecarium

 

 

KCR

 

 

Total

 

Carrying amount, December 31, 2021

 

$

8,360

 

 

$

3,028

 

 

$

1,147

 

 

$

12,535

 

Payments of contingent consideration

 

 

(7,040

)

 

 

 

 

 

 

 

 

(7,040

)

Revaluation of contingent consideration

 

 

86

 

 

 

 

 

 

67

 

 

 

153

 

Carrying amount, June 30, 2022

 

$

1,406

 

 

$

3,028

 

 

$

1,214

 

 

$

5,648

 

Less: current portion

 

 

 

 

 

(3,028

)

 

 

 

 

 

(3,028

)

Non-current contingent consideration

 

$

1,406

 

 

$

-

 

 

$

1,214

 

 

$

2,620

 

During the six months ended June 30, 2022, the Company made payments of $7,040 to the sellers of its previously acquired State Flower business. The remaining amount will be paid to the sellers of State Flower upon the Company's acquisition of the remaining 50.1% of State Flower, which is subject to regulatory approval.

Refer to Note 20 for discussion of valuation methods used when determining the fair value of the contingent consideration liability at June 30, 2022, and the changes in fair value during the six months ended June 30, 2022.